2025 HCPCS Code Q5117
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
| Short Description | Inj., kanjinti, 10 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | October 01, 2019 |
| HCPCS Action Effective Date | October 01, 2019 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4175 - Miroderm
- Q4176 - Neopatch or therion, 1 sq cm
- Q4177 - Floweramnioflo, 0.1 cc
- Q4178 - Floweramniopatch, per sq cm
- Q4179 - Flowerderm, per sq cm
- Q4180 - Revita, per sq cm
- Q4181 - Amnio wound, per square cm
- Q4182 - Transcyte, per sq centimeter
- Q4183 - Surgigraft, 1 sq cm
- Q4184 - Cellesta or duo per sq cm
- Q4185 - Cellesta flowab amnion 0.5cc
- Q4186 - Epifix 1 sq cm
- Q4187 - Epicord 1 sq cm
- Q4188 - Amnioarmor 1 sq cm
- Q4189 - Artacent ac, 1 mg
- Q4190 - Artacent ac 1 sq cm
- Q4191 - Restorigin 1 sq cm
- Q4192 - Restorigin, 1 cc
- Q4193 - Coll-e-derm 1 sq cm
- Q4194 - Novachor 1 sq cm